Inhibitor of Hsp90
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

VER-50589

Item No. 13132

Technical Information
Formal Name
5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-(4-methoxyphenyl)-3-isoxazolecarboxamide
CAS Number
747413-08-7
Molecular Formula
C19H17ClN2O5
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
SMILES
CCNC(=O)c1noc(c1c1ccc(OC)cc1)c1cc(Cl)c(O)cc1O
InChi Code
InChI=1S/C19H17ClN2O5/c1-3-21-19(25)17-16(10-4-6-11(26-2)7-5-10)18(27-22-17)12-8-13(20)15(24)9-14(12)23/h4-9,23-24H,3H2,1-2H3,(H,21,25)
InChi Key
JXPCDMPJCKNLBY-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    VER-50589 is an isoxazole compound that inhibits Hsp90 with an IC50 value of 21 nM.1 It produces a mean cellular antiproliferative GI50 value of 78 nM when tested against a human cancer cell line panel.1 Consistent with inhibition of Hsp90, VER-50589 induces the expression of Hsp27 and Hsp72 while reducing the client proteins C-RAF, B-RAF, survivin, and PRMT5, causing cell cycle arrest and apoptosis.1 VER-50589 shows favorable pharmacokinetics and impairs tumor growth in animals.1 Importantly, glioblastoma cells do not acquire resistance to VER-50589 and resistance to other Hsp90 inhibitors does not produce cross-resistance to VER-50589.2

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Sharp, S.Y., Prodromou, C., Boxall, K., et alInhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues. Mol. Cancer Ther. 6(4), 1198-1211 (2007).

    2. Gaspar, N., Sharp, S.Y., Pacey, S., et alAcquired resistance to 17-allylamino-17-demethoxygeldanamycin (17-AAG, tanespimycin) in glioblastoma cells. Cancer Res. 69(5), 1966-1975 (2009).